Neihulizumab
AltruBio
we re looking forward to the crohn s &amp; colitis congress #cccongress23 where will present a poster on our phase 2 trial in #ulcerativecolitis. join dr. david rubin and members of the altrubio executive team in denver january 19-21. learn more: 
AltruBio is developing first-in-class #ImmuneModulators targeting diseases in #immunology and #inflammation with world class experts in #drugdevelopment